Searches , social queries for OLUTASIDENIB

Search references for OLUTASIDENIB. Phrases containing OLUTASIDENIB

See searches and references containing OLUTASIDENIB!

Searches containing OLUTASIDENIB

OLUTASIDENIB

  • Olutasidenib

    • Anticancer drug

    Olutasidenib, sold under the brand name Rezlidhia, is an anticancer medication used to treat relapsed or refractory acute myeloid leukemia with a susceptible

    Olutasidenib

    Olutasidenib

    Olutasidenib

  • Venetoclax

    • Medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Venetoclax

    Venetoclax

    Venetoclax

  • Eflornithine

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Eflornithine

    Eflornithine

    Eflornithine

  • Etoposide

    • Chemotherapy medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Etoposide

    Etoposide

    Etoposide

  • Sotorasib

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Sotorasib

    Sotorasib

    Sotorasib

  • Trabectedin

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Trabectedin

    Trabectedin

    Trabectedin

  • Docetaxel

    • Chemotherapy medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Docetaxel

    Docetaxel

    Docetaxel

  • Pemetrexed

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Pemetrexed

    Pemetrexed

    Pemetrexed

  • Cancer immunotherapy

    • Artificial stimulation of the immune system to treat cancer

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Cancer immunotherapy

    Cancer immunotherapy

    Cancer_immunotherapy

  • Talimogene laherparepvec

    • Gene therapy medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Talimogene laherparepvec

    Talimogene laherparepvec

    Talimogene_laherparepvec

  • Nadofaragene firadenovec

    • Gene therapy medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Nadofaragene firadenovec

    Nadofaragene_firadenovec

  • Doxorubicin

    • Chemotherapy medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Doxorubicin

    Doxorubicin

    Doxorubicin

  • Stanford V

    • Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Stanford V

    Stanford_V

  • Dactolisib

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Dactolisib

    Dactolisib

    Dactolisib

  • Celecoxib

    • Nonsteroidal anti-inflammatory medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Celecoxib

    Celecoxib

    Celecoxib

  • Arsenic trioxide

    • Industrial chemical and medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Arsenic trioxide

    Arsenic trioxide

    Arsenic_trioxide

  • Exisulind

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Exisulind

    Exisulind

    Exisulind

  • Triplatin tetranitrate

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Triplatin tetranitrate

    Triplatin_tetranitrate

  • Acute myeloid leukemia

    • Cancer of the myeloid line of blood cells

    approved by the FDA are: Midostaurin Gilteritinib Quizartinib Ivosidenib Olutasidenib Enasidenib Venetoclax Glasdegib Revumenib Ziftomenib Stem cell transplantation

    Acute myeloid leukemia

    Acute myeloid leukemia

    Acute_myeloid_leukemia

  • Selinexor

    • Anti-cancer drug

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Selinexor

    Selinexor

    Selinexor

  • Fluorouracil

    • Chemotherapy medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Fluorouracil

    Fluorouracil

  • Methotrexate

    • Chemotherapy and immunosuppressant medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Methotrexate

    Methotrexate

    Methotrexate

  • Proteasome inhibitor

    • Drug

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Proteasome inhibitor

    Proteasome inhibitor

    Proteasome_inhibitor

  • Tretinoin

    • Medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Tretinoin

    Tretinoin

    Tretinoin

  • Isocitrate dehydrogenase 1

    • Protein found in humans

    reduce D-2HG levels is a critical component of its mechanism of action. Olutasidenib and vorasidenib are both IDH1 inhibitors that have been approved for

    Isocitrate dehydrogenase 1

    Isocitrate dehydrogenase 1

    Isocitrate_dehydrogenase_1

  • Nitrogen mustard

    • Family of chemical compounds

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Nitrogen mustard

    Nitrogen mustard

    Nitrogen_mustard

  • Hydroxycarbamide

    • Medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Hydroxycarbamide

    Hydroxycarbamide

    Hydroxycarbamide

  • Padeliporfin

    • Medication for prostate cancer

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Padeliporfin

    Padeliporfin

    Padeliporfin

  • Cell-cycle nonspecific antineoplastic agents

    • Class of pharmaceuticals

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Cell-cycle nonspecific antineoplastic agents

    Cell-cycle_nonspecific_antineoplastic_agents

  • Seliciclib

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Seliciclib

    Seliciclib

    Seliciclib

  • Belotecan

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Belotecan

    Belotecan

    Belotecan

  • Plitidepsin

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Plitidepsin

    Plitidepsin

    Plitidepsin

  • Nimustine

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Nimustine

    Nimustine

    Nimustine

  • Carboplatin

    • Medication used to treat cancer

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Carboplatin

    Carboplatin

    Carboplatin

  • Temozolomide

    • Cancer medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Temozolomide

    Temozolomide

    Temozolomide

  • Lurtotecan

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Lurtotecan

    Lurtotecan

    Lurtotecan

  • Gemcitabine

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Gemcitabine

    Gemcitabine

    Gemcitabine

  • Bortezomib

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Bortezomib

    Bortezomib

    Bortezomib

  • Bay 1436032

    • Pharmaceutical compound

    continues to be researched in combination with other drugs. Ivosidenib Olutasidenib Vorasidenib Chaturvedi A, Herbst L, Pusch S, Klett L, Goparaju R, Stichel

    Bay 1436032

    Bay 1436032

    Bay_1436032

  • Alkylating antineoplastic agent

    • Pharmaceutical drugs

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Alkylating antineoplastic agent

    Alkylating antineoplastic agent

    Alkylating_antineoplastic_agent

  • Utidelone

    • Drug for treatment of breast cancer

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Utidelone

    Utidelone

    Utidelone

  • Protein-bound paclitaxel

    • Cancer drug

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Protein-bound paclitaxel

    Protein-bound_paclitaxel

  • Capecitabine

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Capecitabine

    Capecitabine

    Capecitabine

  • Vincristine

    • Chemical compound; chemotherapy medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Vincristine

    Vincristine

    Vincristine

  • ATC code L01

    • Pharmaceutical drug classification

    Obecabtagene autoleucel L01XM01 Enasidenib L01XM02 Ivosidenib L01XM03 Olutasidenib L01XM04 Vorasidenib Empty group L01XX01 Amsacrine L01XX02 Asparaginase

    ATC code L01

    ATC_code_L01

  • Ciltacabtagene autoleucel

    • Gene therapy medication used to treat multiple myeloma

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Ciltacabtagene autoleucel

    Ciltacabtagene_autoleucel

  • Vusolimogene oderparepvec

    • Medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Vusolimogene oderparepvec

    Vusolimogene_oderparepvec

  • Abemaciclib

    • Anti-breast cancer medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Abemaciclib

    Abemaciclib

    Abemaciclib

  • Chlormethine

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Chlormethine

    Chlormethine

    Chlormethine

  • Vinblastine

    • Chemotherapy medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Vinblastine

    Vinblastine

    Vinblastine

  • FOLFIRI

    • Chemotherapy regimen for colorectal cancer treatment

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    FOLFIRI

    FOLFIRI

  • Cytarabine

    • Chemical compound (chemotherapy medication)

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Cytarabine

    Cytarabine

    Cytarabine

  • Idecabtagene vicleucel

    • Gene therapy medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Idecabtagene vicleucel

    Idecabtagene_vicleucel

  • Oxaliplatin

    • Pharmaceutical drug

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Oxaliplatin

    Oxaliplatin

    Oxaliplatin

  • Paclitaxel

    • Medication used for cancer

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Paclitaxel

    Paclitaxel

    Paclitaxel

  • Lisocabtagene maraleucel

    • Gene therapy medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Lisocabtagene maraleucel

    Lisocabtagene_maraleucel

  • Lifileucel

    • Medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Lifileucel

    Lifileucel

  • Platinum-based antineoplastic

    • Chemotherapeutic agents used to treat cancer

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Platinum-based antineoplastic

    Platinum-based_antineoplastic

  • Azacitidine

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Azacitidine

    Azacitidine

    Azacitidine

  • Cisplatin

    • Chemical compound and pharmaceutical drug

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Cisplatin

    Cisplatin

    Cisplatin

  • Tebentafusp

    • Pharmaceutical drug

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Tebentafusp

    Tebentafusp

  • Decitabine/cedazuridine

    • Medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Decitabine/cedazuridine

    Decitabine/cedazuridine

    Decitabine/cedazuridine

  • Chemotherapy-induced nausea and vomiting

    • Common side effects in chemotherapy treatment

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Chemotherapy-induced nausea and vomiting

    Chemotherapy-induced_nausea_and_vomiting

  • Cyclophosphamide

    • Medication used as chemotherapy and to suppress the immune system

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Cyclophosphamide

    Cyclophosphamide

    Cyclophosphamide

  • Mitomycin C

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Mitomycin C

    Mitomycin C

    Mitomycin_C

  • List of chemotherapeutic agents

    • Drugs that are useful against cancer

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    List of chemotherapeutic agents

    List_of_chemotherapeutic_agents

  • Obecabtagene autoleucel

    • Gene therapy medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Obecabtagene autoleucel

    Obecabtagene_autoleucel

  • Mercaptopurine

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Mercaptopurine

    Mercaptopurine

    Mercaptopurine

  • Photodynamic therapy

    • Form of phototherapy

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Photodynamic therapy

    Photodynamic therapy

    Photodynamic_therapy

  • Pelabresib

    • Investigational oral small-molecule drug

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Pelabresib

    Pelabresib

    Pelabresib

  • Vorasidenib

    • Anti-cancer medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Vorasidenib

    Vorasidenib

    Vorasidenib

  • Aminolevulinic acid

    • Endogenous non-proteinogenic amino acid

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Aminolevulinic acid

    Aminolevulinic acid

    Aminolevulinic_acid

  • Dordaviprone

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Dordaviprone

    Dordaviprone

    Dordaviprone

  • Irinotecan

    • Cancer medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Irinotecan

    Irinotecan

    Irinotecan

  • Antineoplastic

    • Class of drugs used to treat malignant tumors

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Antineoplastic

    Antineoplastic

    Antineoplastic

  • Olaparib

    • Chemical compound (cancer therapy drug)

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Olaparib

    Olaparib

    Olaparib

  • Imetelstat

    • Medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Imetelstat

    Imetelstat

    Imetelstat

  • Talazoparib

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Talazoparib

    Talazoparib

    Talazoparib

  • Vepdegestrant

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Vepdegestrant

    Vepdegestrant

    Vepdegestrant

  • Protein kinase inhibitor

    • Enzymes that block actions of protein kinases

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Protein kinase inhibitor

    Protein_kinase_inhibitor

  • Hazardous drug

    • Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Hazardous drug

    Hazardous_drug

  • Navitoclax

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Navitoclax

    Navitoclax

    Navitoclax

  • Adagrasib

    • Medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Adagrasib

    Adagrasib

    Adagrasib

  • Melphalan

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Melphalan

    Melphalan

    Melphalan

  • Bleomycin

    • Glycopeptide antibiotic used to treat various cancers

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Bleomycin

    Bleomycin

    Bleomycin

  • Lurbinectedin

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Lurbinectedin

    Lurbinectedin

    Lurbinectedin

  • Daunorubicin

    • Chemotherapy medication

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Daunorubicin

    Daunorubicin

    Daunorubicin

  • Bendamustine

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Bendamustine

    Bendamustine

    Bendamustine

  • Anagrelide

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Anagrelide

    Anagrelide

    Anagrelide

  • Busulfan

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Busulfan

    Busulfan

    Busulfan

  • Anthracycline

    • Class of antibiotics

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Anthracycline

    Anthracycline

    Anthracycline

  • Chemotherapy regimen

    • Regimen commonly used in chemotherapy

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Chemotherapy regimen

    Chemotherapy_regimen

  • Ribociclib

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Ribociclib

    Ribociclib

    Ribociclib

  • Camptothecin

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Camptothecin

    Camptothecin

    Camptothecin

  • Rabacfosadine

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Rabacfosadine

    Rabacfosadine

    Rabacfosadine

  • Antimetabolite

    • Chemical that inhibits the use of a metabolite

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Antimetabolite

    Antimetabolite

    Antimetabolite

  • Asparaginase

    • Enzyme used as medication and in food manufacturing

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Asparaginase

    Asparaginase

    Asparaginase

  • Belzutifan

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Belzutifan

    Belzutifan

    Belzutifan

  • Vorinostat

    • Pharmaceutical drug

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Vorinostat

    Vorinostat

  • Prednimustine

    • Chemical compound

    Duvelisib Idelalisib Inavolisib Umbralisib‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib) KRAS (Adagrasib Garsorasib Sotorasib) Receptor antagonists

    Prednimustine

    Prednimustine

    Prednimustine

Affordable travel, tourism, home and auto insurance, legal services

travel, tourism, insurance

Searches for online references containing OLUTASIDENIB

OLUTASIDENIB

Search references containing OLUTASIDENIB

OLUTASIDENIB

Search queries for Facebook and twitter posts, hashtags with OLUTASIDENIB

OLUTASIDENIB

Follow users with usernames @OLUTASIDENIB or posting hashtags containing #OLUTASIDENIB

OLUTASIDENIB

Online names & meanings

Search queries for Facebook and twitter users, user names, hashtags with OLUTASIDENIB

OLUTASIDENIB

Top search, Social media, medium, facebook & news articles containing OLUTASIDENIB

OLUTASIDENIB

Searches for Acronyms & meanings containing OLUTASIDENIB

OLUTASIDENIB

Searches, Indeed job searches and job offers containing OLUTASIDENIB

Other words and meanings similar to

OLUTASIDENIB

Search in online dictionary sources & meanings containing OLUTASIDENIB

OLUTASIDENIB

Affordable travel, tourism, home and auto insurance, legal services

travel, tourism, insurance